http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011236053-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a913274c63c419fde9a6021d18a9b7e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2011-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a10f7e8557b7bc1e354f9191eacd928a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4516c3cc33d1d8f920f5eada878e45d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07e05f308b7ce494c157ed1c7a54e041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_528239cdaa7721e8a31132c144868e2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a4e73ab3b4e07cd92337f42bd50b1a4
publicationDate 2014-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2011236053-B2
titleOfInvention Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
abstract DRUG COMBINATION COMPRISING A SELECTIVE SEROTONIN REUPTAKE INHIBITOR AND A GLUCOCORTICOID RECEPTOR ANTAGONIST FOR THE TREATMENT OF DEPRESSION Abstract s The invention provides for a combination comprising an amount of an SSRI, or a pharmaceutically acceptable salt or solvate thereof, and an amount of a GR antagonist, or a pharmaceutically acceptable salt or solvate thereof, optionally in association with one or more pharmaceutically acceptable carriers for use as therapy for depression and related disorders.
priorityDate 2004-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003162695-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004030618-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03037354-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414874943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID143490893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427794987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66926087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29922413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426266256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432014150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505924

Total number of triples: 46.